aluates Reports

$ 0.0

Automative

Global Antiprotozoal Drugs Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-28Z5714

Global Antiprotozoal Drugs Market Insights and Forecast to 2028

BUY CHAPTERS

Global Antiprotozoal Drugs Market Research Report 2025

Code: QYRE-Auto-28Z5714

Report

July 2025

Pages:113

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sanofi

Akthelia Pharmaceuticals Ltd

GlaxoSmithKline PLC

Immuron

Microbiotix Inc

Protein Potential LLC

Dr. Reddy’s Laboratories

Mission Pharmacal

Aceto Corp.

Mylan Pharmaceuticals

Impax Laboratories

Pfizer Inc

Lupin Pharmaceuticals

Glenmark Pharmaceuticals

Sun Pharmaceutical

Heritage Pharmaceuticals

Gilead Sciences

Johnson & Johnson

Bristol–Myers Squibb

Profounda

Knight Therapeutics

Albert David

WANLONG

Fangsheng

KPC Pharmaceuticals

Guilin Pharmaceuticals

Pude Pharmaceutica

Antiprotozoal Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Antiprotozoal Drugs Market

The global market for Antiprotozoal Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Antiprotozoal agents (ATC code: ATC P01) is a class of pharmaceuticals used in treatment of protozoan infection.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Antiprotozoal Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiprotozoal Drugs.

The Antiprotozoal Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antiprotozoal Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Antiprotozoal Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Antiprotozoal Drugs Market Report

Report Metric	Details
Report Name	Antiprotozoal Drugs Market
CAGR	5%
Segment by Type	by Diseases by Drugs
Segment by Application	Hospital Clinic
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi, Akthelia Pharmaceuticals Ltd, GlaxoSmithKline Plc, Immuron Ltd, Microbiotix Inc, Protein Potential LLC, Dr. Reddy’s Laboratories, Mission Pharmacal, Aceto Corp., Mylan Pharmaceuticals, Impax Laboratories, Pfizer, Lupin Pharmaceuticals, Glenmark Pharmaceuticals, Sun Pharmaceutical, Heritage Pharmaceuticals, Gilead Sciences, Johnson & Johnson, Bristol-Myers Squibb, Profounda, Knight Therapeutics, Albert David, Wanlong, Fangsheng, KPC Pharmaceuticals, Guilin Pharmaceuticals, Pude Pharmaceutica
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antiprotozoal Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Antiprotozoal Drugs Market report?

Ans: The main players in the Antiprotozoal Drugs Market are Sanofi, Akthelia Pharmaceuticals Ltd, GlaxoSmithKline Plc, Immuron Ltd, Microbiotix Inc, Protein Potential LLC, Dr. Reddy’s Laboratories, Mission Pharmacal, Aceto Corp., Mylan Pharmaceuticals, Impax Laboratories, Pfizer, Lupin Pharmaceuticals, Glenmark Pharmaceuticals, Sun Pharmaceutical, Heritage Pharmaceuticals, Gilead Sciences, Johnson & Johnson, Bristol-Myers Squibb, Profounda, Knight Therapeutics, Albert David, Wanlong, Fangsheng, KPC Pharmaceuticals, Guilin Pharmaceuticals, Pude Pharmaceutica

What are the Application segmentation covered in the Antiprotozoal Drugs Market report?

Ans: The Applications covered in the Antiprotozoal Drugs Market report are Hospital, Clinic

What are the Type segmentation covered in the Antiprotozoal Drugs Market report?

Ans: The Types covered in the Antiprotozoal Drugs Market report are by Diseases, by Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Antiprotozoal Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 by Diseases

1.2.3 by Drugs

1.3 Market by Application

1.3.1 Global Antiprotozoal Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Antiprotozoal Drugs Market Perspective (2020-2031)

2.2 Global Antiprotozoal Drugs Growth Trends by Region

2.2.1 Global Antiprotozoal Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Antiprotozoal Drugs Historic Market Size by Region (2020-2025)

2.2.3 Antiprotozoal Drugs Forecasted Market Size by Region (2026-2031)

2.3 Antiprotozoal Drugs Market Dynamics

2.3.1 Antiprotozoal Drugs Industry Trends

2.3.2 Antiprotozoal Drugs Market Drivers

2.3.3 Antiprotozoal Drugs Market Challenges

2.3.4 Antiprotozoal Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Antiprotozoal Drugs Players by Revenue

3.1.1 Global Top Antiprotozoal Drugs Players by Revenue (2020-2025)

3.1.2 Global Antiprotozoal Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Antiprotozoal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Antiprotozoal Drugs Revenue

3.4 Global Antiprotozoal Drugs Market Concentration Ratio

3.4.1 Global Antiprotozoal Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Antiprotozoal Drugs Revenue in 2024

3.5 Global Key Players of Antiprotozoal Drugs Head office and Area Served

3.6 Global Key Players of Antiprotozoal Drugs, Product and Application

3.7 Global Key Players of Antiprotozoal Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Antiprotozoal Drugs Breakdown Data by Type

4.1 Global Antiprotozoal Drugs Historic Market Size by Type (2020-2025)

4.2 Global Antiprotozoal Drugs Forecasted Market Size by Type (2026-2031)

5 Antiprotozoal Drugs Breakdown Data by Application

5.1 Global Antiprotozoal Drugs Historic Market Size by Application (2020-2025)

5.2 Global Antiprotozoal Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Antiprotozoal Drugs Market Size (2020-2031)

6.2 North America Antiprotozoal Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Antiprotozoal Drugs Market Size by Country (2020-2025)

6.4 North America Antiprotozoal Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Antiprotozoal Drugs Market Size (2020-2031)

7.2 Europe Antiprotozoal Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Antiprotozoal Drugs Market Size by Country (2020-2025)

7.4 Europe Antiprotozoal Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Antiprotozoal Drugs Market Size (2020-2031)

8.2 Asia-Pacific Antiprotozoal Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Antiprotozoal Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific Antiprotozoal Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Antiprotozoal Drugs Market Size (2020-2031)

9.2 Latin America Antiprotozoal Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Antiprotozoal Drugs Market Size by Country (2020-2025)

9.4 Latin America Antiprotozoal Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Antiprotozoal Drugs Market Size (2020-2031)

10.2 Middle East & Africa Antiprotozoal Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Antiprotozoal Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa Antiprotozoal Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Sanofi

11.1.1 Sanofi Company Details

11.1.2 Sanofi Business Overview

11.1.3 Sanofi Antiprotozoal Drugs Introduction

11.1.4 Sanofi Revenue in Antiprotozoal Drugs Business (2020-2025)

11.1.5 Sanofi Recent Development

11.2 Akthelia Pharmaceuticals Ltd

11.2.1 Akthelia Pharmaceuticals Ltd Company Details

11.2.2 Akthelia Pharmaceuticals Ltd Business Overview

11.2.3 Akthelia Pharmaceuticals Ltd Antiprotozoal Drugs Introduction

11.2.4 Akthelia Pharmaceuticals Ltd Revenue in Antiprotozoal Drugs Business (2020-2025)

11.2.5 Akthelia Pharmaceuticals Ltd Recent Development

11.3 GlaxoSmithKline Plc

11.3.1 GlaxoSmithKline Plc Company Details

11.3.2 GlaxoSmithKline Plc Business Overview

11.3.3 GlaxoSmithKline Plc Antiprotozoal Drugs Introduction

11.3.4 GlaxoSmithKline Plc Revenue in Antiprotozoal Drugs Business (2020-2025)

11.3.5 GlaxoSmithKline Plc Recent Development

11.4 Immuron Ltd

11.4.1 Immuron Ltd Company Details

11.4.2 Immuron Ltd Business Overview

11.4.3 Immuron Ltd Antiprotozoal Drugs Introduction

11.4.4 Immuron Ltd Revenue in Antiprotozoal Drugs Business (2020-2025)

11.4.5 Immuron Ltd Recent Development

11.5 Microbiotix Inc

11.5.1 Microbiotix Inc Company Details

11.5.2 Microbiotix Inc Business Overview

11.5.3 Microbiotix Inc Antiprotozoal Drugs Introduction

11.5.4 Microbiotix Inc Revenue in Antiprotozoal Drugs Business (2020-2025)

11.5.5 Microbiotix Inc Recent Development

11.6 Protein Potential LLC

11.6.1 Protein Potential LLC Company Details

11.6.2 Protein Potential LLC Business Overview

11.6.3 Protein Potential LLC Antiprotozoal Drugs Introduction

11.6.4 Protein Potential LLC Revenue in Antiprotozoal Drugs Business (2020-2025)

11.6.5 Protein Potential LLC Recent Development

11.7 Dr. Reddy’s Laboratories

11.7.1 Dr. Reddy’s Laboratories Company Details

11.7.2 Dr. Reddy’s Laboratories Business Overview

11.7.3 Dr. Reddy’s Laboratories Antiprotozoal Drugs Introduction

11.7.4 Dr. Reddy’s Laboratories Revenue in Antiprotozoal Drugs Business (2020-2025)

11.7.5 Dr. Reddy’s Laboratories Recent Development

11.8 Mission Pharmacal

11.8.1 Mission Pharmacal Company Details

11.8.2 Mission Pharmacal Business Overview

11.8.3 Mission Pharmacal Antiprotozoal Drugs Introduction

11.8.4 Mission Pharmacal Revenue in Antiprotozoal Drugs Business (2020-2025)

11.8.5 Mission Pharmacal Recent Development

11.9 Aceto Corp.

11.9.1 Aceto Corp. Company Details

11.9.2 Aceto Corp. Business Overview

11.9.3 Aceto Corp. Antiprotozoal Drugs Introduction

11.9.4 Aceto Corp. Revenue in Antiprotozoal Drugs Business (2020-2025)

11.9.5 Aceto Corp. Recent Development

11.10 Mylan Pharmaceuticals

11.10.1 Mylan Pharmaceuticals Company Details

11.10.2 Mylan Pharmaceuticals Business Overview

11.10.3 Mylan Pharmaceuticals Antiprotozoal Drugs Introduction

11.10.4 Mylan Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2020-2025)

11.10.5 Mylan Pharmaceuticals Recent Development

11.11 Impax Laboratories

11.11.1 Impax Laboratories Company Details

11.11.2 Impax Laboratories Business Overview

11.11.3 Impax Laboratories Antiprotozoal Drugs Introduction

11.11.4 Impax Laboratories Revenue in Antiprotozoal Drugs Business (2020-2025)

11.11.5 Impax Laboratories Recent Development

11.12 Pfizer

11.12.1 Pfizer Company Details

11.12.2 Pfizer Business Overview

11.12.3 Pfizer Antiprotozoal Drugs Introduction

11.12.4 Pfizer Revenue in Antiprotozoal Drugs Business (2020-2025)

11.12.5 Pfizer Recent Development

11.13 Lupin Pharmaceuticals

11.13.1 Lupin Pharmaceuticals Company Details

11.13.2 Lupin Pharmaceuticals Business Overview

11.13.3 Lupin Pharmaceuticals Antiprotozoal Drugs Introduction

11.13.4 Lupin Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2020-2025)

11.13.5 Lupin Pharmaceuticals Recent Development

11.14 Glenmark Pharmaceuticals

11.14.1 Glenmark Pharmaceuticals Company Details

11.14.2 Glenmark Pharmaceuticals Business Overview

11.14.3 Glenmark Pharmaceuticals Antiprotozoal Drugs Introduction

11.14.4 Glenmark Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2020-2025)

11.14.5 Glenmark Pharmaceuticals Recent Development

11.15 Sun Pharmaceutical

11.15.1 Sun Pharmaceutical Company Details

11.15.2 Sun Pharmaceutical Business Overview

11.15.3 Sun Pharmaceutical Antiprotozoal Drugs Introduction

11.15.4 Sun Pharmaceutical Revenue in Antiprotozoal Drugs Business (2020-2025)

11.15.5 Sun Pharmaceutical Recent Development

11.16 Heritage Pharmaceuticals

11.16.1 Heritage Pharmaceuticals Company Details

11.16.2 Heritage Pharmaceuticals Business Overview

11.16.3 Heritage Pharmaceuticals Antiprotozoal Drugs Introduction

11.16.4 Heritage Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2020-2025)

11.16.5 Heritage Pharmaceuticals Recent Development

11.17 Gilead Sciences

11.17.1 Gilead Sciences Company Details

11.17.2 Gilead Sciences Business Overview

11.17.3 Gilead Sciences Antiprotozoal Drugs Introduction

11.17.4 Gilead Sciences Revenue in Antiprotozoal Drugs Business (2020-2025)

11.17.5 Gilead Sciences Recent Development

11.18 Johnson & Johnson

11.18.1 Johnson & Johnson Company Details

11.18.2 Johnson & Johnson Business Overview

11.18.3 Johnson & Johnson Antiprotozoal Drugs Introduction

11.18.4 Johnson & Johnson Revenue in Antiprotozoal Drugs Business (2020-2025)

11.18.5 Johnson & Johnson Recent Development

11.19 Bristol-Myers Squibb

11.19.1 Bristol-Myers Squibb Company Details

11.19.2 Bristol-Myers Squibb Business Overview

11.19.3 Bristol-Myers Squibb Antiprotozoal Drugs Introduction

11.19.4 Bristol-Myers Squibb Revenue in Antiprotozoal Drugs Business (2020-2025)

11.19.5 Bristol-Myers Squibb Recent Development

11.20 Profounda

11.20.1 Profounda Company Details

11.20.2 Profounda Business Overview

11.20.3 Profounda Antiprotozoal Drugs Introduction

11.20.4 Profounda Revenue in Antiprotozoal Drugs Business (2020-2025)

11.20.5 Profounda Recent Development

11.21 Knight Therapeutics

11.21.1 Knight Therapeutics Company Details

11.21.2 Knight Therapeutics Business Overview

11.21.3 Knight Therapeutics Antiprotozoal Drugs Introduction

11.21.4 Knight Therapeutics Revenue in Antiprotozoal Drugs Business (2020-2025)

11.21.5 Knight Therapeutics Recent Development

11.22 Albert David

11.22.1 Albert David Company Details

11.22.2 Albert David Business Overview

11.22.3 Albert David Antiprotozoal Drugs Introduction

11.22.4 Albert David Revenue in Antiprotozoal Drugs Business (2020-2025)

11.22.5 Albert David Recent Development

11.23 Wanlong

11.23.1 Wanlong Company Details

11.23.2 Wanlong Business Overview

11.23.3 Wanlong Antiprotozoal Drugs Introduction

11.23.4 Wanlong Revenue in Antiprotozoal Drugs Business (2020-2025)

11.23.5 Wanlong Recent Development

11.24 Fangsheng

11.24.1 Fangsheng Company Details

11.24.2 Fangsheng Business Overview

11.24.3 Fangsheng Antiprotozoal Drugs Introduction

11.24.4 Fangsheng Revenue in Antiprotozoal Drugs Business (2020-2025)

11.24.5 Fangsheng Recent Development

11.25 KPC Pharmaceuticals

11.25.1 KPC Pharmaceuticals Company Details

11.25.2 KPC Pharmaceuticals Business Overview

11.25.3 KPC Pharmaceuticals Antiprotozoal Drugs Introduction

11.25.4 KPC Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2020-2025)

11.25.5 KPC Pharmaceuticals Recent Development

11.26 Guilin Pharmaceuticals

11.26.1 Guilin Pharmaceuticals Company Details

11.26.2 Guilin Pharmaceuticals Business Overview

11.26.3 Guilin Pharmaceuticals Antiprotozoal Drugs Introduction

11.26.4 Guilin Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2020-2025)

11.26.5 Guilin Pharmaceuticals Recent Development

11.27 Pude Pharmaceutica

11.27.1 Pude Pharmaceutica Company Details

11.27.2 Pude Pharmaceutica Business Overview

11.27.3 Pude Pharmaceutica Antiprotozoal Drugs Introduction

11.27.4 Pude Pharmaceutica Revenue in Antiprotozoal Drugs Business (2020-2025)

11.27.5 Pude Pharmaceutica Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Sanofi

Akthelia Pharmaceuticals Ltd

GlaxoSmithKline PLC

Immuron

Microbiotix Inc

Protein Potential LLC

Dr. Reddy’s Laboratories

Mission Pharmacal

Aceto Corp.

Mylan Pharmaceuticals

Impax Laboratories

Pfizer Inc

Lupin Pharmaceuticals

Glenmark Pharmaceuticals

Sun Pharmaceutical

Heritage Pharmaceuticals

Gilead Sciences

Johnson & Johnson

Bristol–Myers Squibb

Profounda

Knight Therapeutics

Albert David

WANLONG

Fangsheng

KPC Pharmaceuticals

Guilin Pharmaceuticals

Pude Pharmaceutica

List of Tables

Table 1. Global Antiprotozoal Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of by Diseases

Table 3. Key Players of by Drugs

Table 4. Global Antiprotozoal Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Antiprotozoal Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Antiprotozoal Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Antiprotozoal Drugs Market Share by Region (2020-2025)

Table 8. Global Antiprotozoal Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Antiprotozoal Drugs Market Share by Region (2026-2031)

Table 10. Antiprotozoal Drugs Market Trends

Table 11. Antiprotozoal Drugs Market Drivers

Table 12. Antiprotozoal Drugs Market Challenges

Table 13. Antiprotozoal Drugs Market Restraints

Table 14. Global Antiprotozoal Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Antiprotozoal Drugs Market Share by Players (2020-2025)

Table 16. Global Top Antiprotozoal Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiprotozoal Drugs as of 2024)

Table 17. Ranking of Global Top Antiprotozoal Drugs Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Antiprotozoal Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Antiprotozoal Drugs, Headquarters and Area Served

Table 20. Global Key Players of Antiprotozoal Drugs, Product and Application

Table 21. Global Key Players of Antiprotozoal Drugs, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Antiprotozoal Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Antiprotozoal Drugs Revenue Market Share by Type (2020-2025)

Table 25. Global Antiprotozoal Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Antiprotozoal Drugs Revenue Market Share by Type (2026-2031)

Table 27. Global Antiprotozoal Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Antiprotozoal Drugs Revenue Market Share by Application (2020-2025)

Table 29. Global Antiprotozoal Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Antiprotozoal Drugs Revenue Market Share by Application (2026-2031)

Table 31. North America Antiprotozoal Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Antiprotozoal Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Antiprotozoal Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Antiprotozoal Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Antiprotozoal Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Antiprotozoal Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Antiprotozoal Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Antiprotozoal Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Antiprotozoal Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Antiprotozoal Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Antiprotozoal Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Antiprotozoal Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Antiprotozoal Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Antiprotozoal Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Antiprotozoal Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 46. Sanofi Company Details

Table 47. Sanofi Business Overview

Table 48. Sanofi Antiprotozoal Drugs Product

Table 49. Sanofi Revenue in Antiprotozoal Drugs Business (2020-2025) & (US$ Million)

Table 50. Sanofi Recent Development

Table 51. Akthelia Pharmaceuticals Ltd Company Details

Table 52. Akthelia Pharmaceuticals Ltd Business Overview

Table 53. Akthelia Pharmaceuticals Ltd Antiprotozoal Drugs Product

Table 54. Akthelia Pharmaceuticals Ltd Revenue in Antiprotozoal Drugs Business (2020-2025) & (US$ Million)

Table 55. Akthelia Pharmaceuticals Ltd Recent Development

Table 56. GlaxoSmithKline Plc Company Details

Table 57. GlaxoSmithKline Plc Business Overview

Table 58. GlaxoSmithKline Plc Antiprotozoal Drugs Product

Table 59. GlaxoSmithKline Plc Revenue in Antiprotozoal Drugs Business (2020-2025) & (US$ Million)

Table 60. GlaxoSmithKline Plc Recent Development

Table 61. Immuron Ltd Company Details

Table 62. Immuron Ltd Business Overview

Table 63. Immuron Ltd Antiprotozoal Drugs Product

Table 64. Immuron Ltd Revenue in Antiprotozoal Drugs Business (2020-2025) & (US$ Million)

Table 65. Immuron Ltd Recent Development

Table 66. Microbiotix Inc Company Details

Table 67. Microbiotix Inc Business Overview

Table 68. Microbiotix Inc Antiprotozoal Drugs Product

Table 69. Microbiotix Inc Revenue in Antiprotozoal Drugs Business (2020-2025) & (US$ Million)

Table 70. Microbiotix Inc Recent Development

Table 71. Protein Potential LLC Company Details

Table 72. Protein Potential LLC Business Overview

Table 73. Protein Potential LLC Antiprotozoal Drugs Product

Table 74. Protein Potential LLC Revenue in Antiprotozoal Drugs Business (2020-2025) & (US$ Million)

Table 75. Protein Potential LLC Recent Development

Table 76. Dr. Reddy’s Laboratories Company Details

Table 77. Dr. Reddy’s Laboratories Business Overview

Table 78. Dr. Reddy’s Laboratories Antiprotozoal Drugs Product

Table 79. Dr. Reddy’s Laboratories Revenue in Antiprotozoal Drugs Business (2020-2025) & (US$ Million)

Table 80. Dr. Reddy’s Laboratories Recent Development

Table 81. Mission Pharmacal Company Details

Table 82. Mission Pharmacal Business Overview

Table 83. Mission Pharmacal Antiprotozoal Drugs Product

Table 84. Mission Pharmacal Revenue in Antiprotozoal Drugs Business (2020-2025) & (US$ Million)

Table 85. Mission Pharmacal Recent Development

Table 86. Aceto Corp. Company Details

Table 87. Aceto Corp. Business Overview

Table 88. Aceto Corp. Antiprotozoal Drugs Product

Table 89. Aceto Corp. Revenue in Antiprotozoal Drugs Business (2020-2025) & (US$ Million)

Table 90. Aceto Corp. Recent Development

Table 91. Mylan Pharmaceuticals Company Details

Table 92. Mylan Pharmaceuticals Business Overview

Table 93. Mylan Pharmaceuticals Antiprotozoal Drugs Product

Table 94. Mylan Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2020-2025) & (US$ Million)

Table 95. Mylan Pharmaceuticals Recent Development

Table 96. Impax Laboratories Company Details

Table 97. Impax Laboratories Business Overview

Table 98. Impax Laboratories Antiprotozoal Drugs Product

Table 99. Impax Laboratories Revenue in Antiprotozoal Drugs Business (2020-2025) & (US$ Million)

Table 100. Impax Laboratories Recent Development

Table 101. Pfizer Company Details

Table 102. Pfizer Business Overview

Table 103. Pfizer Antiprotozoal Drugs Product

Table 104. Pfizer Revenue in Antiprotozoal Drugs Business (2020-2025) & (US$ Million)

Table 105. Pfizer Recent Development

Table 106. Lupin Pharmaceuticals Company Details

Table 107. Lupin Pharmaceuticals Business Overview

Table 108. Lupin Pharmaceuticals Antiprotozoal Drugs Product

Table 109. Lupin Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2020-2025) & (US$ Million)

Table 110. Lupin Pharmaceuticals Recent Development

Table 111. Glenmark Pharmaceuticals Company Details

Table 112. Glenmark Pharmaceuticals Business Overview

Table 113. Glenmark Pharmaceuticals Antiprotozoal Drugs Product

Table 114. Glenmark Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2020-2025) & (US$ Million)

Table 115. Glenmark Pharmaceuticals Recent Development

Table 116. Sun Pharmaceutical Company Details

Table 117. Sun Pharmaceutical Business Overview

Table 118. Sun Pharmaceutical Antiprotozoal Drugs Product

Table 119. Sun Pharmaceutical Revenue in Antiprotozoal Drugs Business (2020-2025) & (US$ Million)

Table 120. Sun Pharmaceutical Recent Development

Table 121. Heritage Pharmaceuticals Company Details

Table 122. Heritage Pharmaceuticals Business Overview

Table 123. Heritage Pharmaceuticals Antiprotozoal Drugs Product

Table 124. Heritage Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2020-2025) & (US$ Million)

Table 125. Heritage Pharmaceuticals Recent Development

Table 126. Gilead Sciences Company Details

Table 127. Gilead Sciences Business Overview

Table 128. Gilead Sciences Antiprotozoal Drugs Product

Table 129. Gilead Sciences Revenue in Antiprotozoal Drugs Business (2020-2025) & (US$ Million)

Table 130. Gilead Sciences Recent Development

Table 131. Johnson & Johnson Company Details

Table 132. Johnson & Johnson Business Overview

Table 133. Johnson & Johnson Antiprotozoal Drugs Product

Table 134. Johnson & Johnson Revenue in Antiprotozoal Drugs Business (2020-2025) & (US$ Million)

Table 135. Johnson & Johnson Recent Development

Table 136. Bristol-Myers Squibb Company Details

Table 137. Bristol-Myers Squibb Business Overview

Table 138. Bristol-Myers Squibb Antiprotozoal Drugs Product

Table 139. Bristol-Myers Squibb Revenue in Antiprotozoal Drugs Business (2020-2025) & (US$ Million)

Table 140. Bristol-Myers Squibb Recent Development

Table 141. Profounda Company Details

Table 142. Profounda Business Overview

Table 143. Profounda Antiprotozoal Drugs Product

Table 144. Profounda Revenue in Antiprotozoal Drugs Business (2020-2025) & (US$ Million)

Table 145. Profounda Recent Development

Table 146. Knight Therapeutics Company Details

Table 147. Knight Therapeutics Business Overview

Table 148. Knight Therapeutics Antiprotozoal Drugs Product

Table 149. Knight Therapeutics Revenue in Antiprotozoal Drugs Business (2020-2025) & (US$ Million)

Table 150. Knight Therapeutics Recent Development

Table 151. Albert David Company Details

Table 152. Albert David Business Overview

Table 153. Albert David Antiprotozoal Drugs Product

Table 154. Albert David Revenue in Antiprotozoal Drugs Business (2020-2025) & (US$ Million)

Table 155. Albert David Recent Development

Table 156. Wanlong Company Details

Table 157. Wanlong Business Overview

Table 158. Wanlong Antiprotozoal Drugs Product

Table 159. Wanlong Revenue in Antiprotozoal Drugs Business (2020-2025) & (US$ Million)

Table 160. Wanlong Recent Development

Table 161. Fangsheng Company Details

Table 162. Fangsheng Business Overview

Table 163. Fangsheng Antiprotozoal Drugs Product

Table 164. Fangsheng Revenue in Antiprotozoal Drugs Business (2020-2025) & (US$ Million)

Table 165. Fangsheng Recent Development

Table 166. KPC Pharmaceuticals Company Details

Table 167. KPC Pharmaceuticals Business Overview

Table 168. KPC Pharmaceuticals Antiprotozoal Drugs Product

Table 169. KPC Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2020-2025) & (US$ Million)

Table 170. KPC Pharmaceuticals Recent Development

Table 171. Guilin Pharmaceuticals Company Details

Table 172. Guilin Pharmaceuticals Business Overview

Table 173. Guilin Pharmaceuticals Antiprotozoal Drugs Product

Table 174. Guilin Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2020-2025) & (US$ Million)

Table 175. Guilin Pharmaceuticals Recent Development

Table 176. Pude Pharmaceutica Company Details

Table 177. Pude Pharmaceutica Business Overview

Table 178. Pude Pharmaceutica Antiprotozoal Drugs Product

Table 179. Pude Pharmaceutica Revenue in Antiprotozoal Drugs Business (2020-2025) & (US$ Million)

Table 180. Pude Pharmaceutica Recent Development

Table 181. Research Programs/Design for This Report

Table 182. Key Data Information from Secondary Sources

Table 183. Key Data Information from Primary Sources

Table 184. Authors List of This Report

List of Figures

Figure 1. Antiprotozoal Drugs Picture

Figure 2. Global Antiprotozoal Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Antiprotozoal Drugs Market Share by Type: 2024 VS 2031

Figure 4. by Diseases Features

Figure 5. by Drugs Features

Figure 6. Global Antiprotozoal Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Antiprotozoal Drugs Market Share by Application: 2024 VS 2031

Figure 8. Hospital Case Studies

Figure 9. Clinic Case Studies

Figure 10. Antiprotozoal Drugs Report Years Considered

Figure 11. Global Antiprotozoal Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 12. Global Antiprotozoal Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Antiprotozoal Drugs Market Share by Region: 2024 VS 2031

Figure 14. Global Antiprotozoal Drugs Market Share by Players in 2024

Figure 15. Global Top Antiprotozoal Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiprotozoal Drugs as of 2024)

Figure 16. The Top 10 and 5 Players Market Share by Antiprotozoal Drugs Revenue in 2024

Figure 17. North America Antiprotozoal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 18. North America Antiprotozoal Drugs Market Share by Country (2020-2031)

Figure 19. United States Antiprotozoal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. Canada Antiprotozoal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Europe Antiprotozoal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Antiprotozoal Drugs Market Share by Country (2020-2031)

Figure 23. Germany Antiprotozoal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. France Antiprotozoal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. U.K. Antiprotozoal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Italy Antiprotozoal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Russia Antiprotozoal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Nordic Countries Antiprotozoal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Asia-Pacific Antiprotozoal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Antiprotozoal Drugs Market Share by Region (2020-2031)

Figure 31. China Antiprotozoal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Japan Antiprotozoal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. South Korea Antiprotozoal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Southeast Asia Antiprotozoal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. India Antiprotozoal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Australia Antiprotozoal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Latin America Antiprotozoal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Antiprotozoal Drugs Market Share by Country (2020-2031)

Figure 39. Mexico Antiprotozoal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Brazil Antiprotozoal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Middle East & Africa Antiprotozoal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Antiprotozoal Drugs Market Share by Country (2020-2031)

Figure 43. Turkey Antiprotozoal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Saudi Arabia Antiprotozoal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. UAE Antiprotozoal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Sanofi Revenue Growth Rate in Antiprotozoal Drugs Business (2020-2025)

Figure 47. Akthelia Pharmaceuticals Ltd Revenue Growth Rate in Antiprotozoal Drugs Business (2020-2025)

Figure 48. GlaxoSmithKline Plc Revenue Growth Rate in Antiprotozoal Drugs Business (2020-2025)

Figure 49. Immuron Ltd Revenue Growth Rate in Antiprotozoal Drugs Business (2020-2025)

Figure 50. Microbiotix Inc Revenue Growth Rate in Antiprotozoal Drugs Business (2020-2025)

Figure 51. Protein Potential LLC Revenue Growth Rate in Antiprotozoal Drugs Business (2020-2025)

Figure 52. Dr. Reddy’s Laboratories Revenue Growth Rate in Antiprotozoal Drugs Business (2020-2025)

Figure 53. Mission Pharmacal Revenue Growth Rate in Antiprotozoal Drugs Business (2020-2025)

Figure 54. Aceto Corp. Revenue Growth Rate in Antiprotozoal Drugs Business (2020-2025)

Figure 55. Mylan Pharmaceuticals Revenue Growth Rate in Antiprotozoal Drugs Business (2020-2025)

Figure 56. Impax Laboratories Revenue Growth Rate in Antiprotozoal Drugs Business (2020-2025)

Figure 57. Pfizer Revenue Growth Rate in Antiprotozoal Drugs Business (2020-2025)

Figure 58. Lupin Pharmaceuticals Revenue Growth Rate in Antiprotozoal Drugs Business (2020-2025)

Figure 59. Glenmark Pharmaceuticals Revenue Growth Rate in Antiprotozoal Drugs Business (2020-2025)

Figure 60. Sun Pharmaceutical Revenue Growth Rate in Antiprotozoal Drugs Business (2020-2025)

Figure 61. Heritage Pharmaceuticals Revenue Growth Rate in Antiprotozoal Drugs Business (2020-2025)

Figure 62. Gilead Sciences Revenue Growth Rate in Antiprotozoal Drugs Business (2020-2025)

Figure 63. Johnson & Johnson Revenue Growth Rate in Antiprotozoal Drugs Business (2020-2025)

Figure 64. Bristol-Myers Squibb Revenue Growth Rate in Antiprotozoal Drugs Business (2020-2025)

Figure 65. Profounda Revenue Growth Rate in Antiprotozoal Drugs Business (2020-2025)

Figure 66. Knight Therapeutics Revenue Growth Rate in Antiprotozoal Drugs Business (2020-2025)

Figure 67. Albert David Revenue Growth Rate in Antiprotozoal Drugs Business (2020-2025)

Figure 68. Wanlong Revenue Growth Rate in Antiprotozoal Drugs Business (2020-2025)

Figure 69. Fangsheng Revenue Growth Rate in Antiprotozoal Drugs Business (2020-2025)

Figure 70. KPC Pharmaceuticals Revenue Growth Rate in Antiprotozoal Drugs Business (2020-2025)

Figure 71. Guilin Pharmaceuticals Revenue Growth Rate in Antiprotozoal Drugs Business (2020-2025)

Figure 72. Pude Pharmaceutica Revenue Growth Rate in Antiprotozoal Drugs Business (2020-2025)

Figure 73. Bottom-up and Top-down Approaches for This Report

Figure 74. Data Triangulation

Figure 75. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Antiparasitic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antiparasitic Drugs for Dogs Market Research Report 2024

Global Antiparasitics Market Research Report 2025

Global Anti infective Drugs for Animals Market Research Report 2024

Anti worm Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Anti Tuberculosis Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Animal Parasite Prevention and Control Drugs Market Research Report 2025

Global Anti Infective Medications Market Research Report 2024

Global Anti anemia Drugs Market Research Report 2024

Antimania Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Ectoparasiticides Market Insights Forecast to 2030

Global Anti tumor Drug Market Research Report 2025

Antihelminthics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Coccidiostat Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global African Trypanosomiasis Treatment Market Research Report 2025

Global Antimetabolite Drugs Market Research Report 2024

Global Anti Mite Drugs Market Research Report 2024

Global Intestinal Anti infective Drugs Market Research Report 2024

Global Medical Anti infective Agent Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions